Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03696758 · ClinicalTrials.gov registry record · Phase 2
Improving Right Ventricular Function in Young Adults Born Preterm
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03696758 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants.
The verdict
NCT03696758, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the short-term effects of sildenafil and metoprolol on heart function in young adults born premature.
Interventions
- PROCEDURE Electrocardiogram
- PROCEDURE Cardiac Magnetic Resonance Imaging
- DRUG Sildenafil
- DRUG Metoprolol
- PROCEDURE Pulmonary Function Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2020-02-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03696758
The ClinicalTrials.gov registry entry for NCT03696758 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Electrocardiogram is the first listed.
NCT03696758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03696758 about?
NCT03696758 is a clinical study titled "Improving Right Ventricular Function in Young Adults Born Preterm". The purpose of this research is to evaluate the short-term effects of sildenafil and metoprolol on heart function in young adults born premature.
What is the current status of trial NCT03696758?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2018-10-30. Estimated completion is 2020-02-24.
What interventions are being tested in trial NCT03696758?
The interventions under investigation include: Electrocardiogram (PROCEDURE), Cardiac Magnetic Resonance Imaging (PROCEDURE), Sildenafil (DRUG), Metoprolol (DRUG), Pulmonary Function Testing (PROCEDURE).
Who is sponsoring clinical trial NCT03696758?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.